1. Home
  2. MLTX vs OFIX Comparison

MLTX vs OFIX Comparison

Compare MLTX & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • OFIX
  • Stock Information
  • Founded
  • MLTX 2021
  • OFIX 1987
  • Country
  • MLTX Switzerland
  • OFIX United States
  • Employees
  • MLTX N/A
  • OFIX N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • OFIX Medical/Dental Instruments
  • Sector
  • MLTX Health Care
  • OFIX Health Care
  • Exchange
  • MLTX Nasdaq
  • OFIX Nasdaq
  • Market Cap
  • MLTX 535.3M
  • OFIX 564.4M
  • IPO Year
  • MLTX N/A
  • OFIX N/A
  • Fundamental
  • Price
  • MLTX $9.40
  • OFIX $14.09
  • Analyst Decision
  • MLTX Buy
  • OFIX Strong Buy
  • Analyst Count
  • MLTX 9
  • OFIX 5
  • Target Price
  • MLTX $37.63
  • OFIX $21.75
  • AVG Volume (30 Days)
  • MLTX 9.7M
  • OFIX 297.3K
  • Earning Date
  • MLTX 11-06-2025
  • OFIX 11-06-2025
  • Dividend Yield
  • MLTX N/A
  • OFIX N/A
  • EPS Growth
  • MLTX N/A
  • OFIX N/A
  • EPS
  • MLTX N/A
  • OFIX N/A
  • Revenue
  • MLTX N/A
  • OFIX $809,030,000.00
  • Revenue This Year
  • MLTX N/A
  • OFIX $3.93
  • Revenue Next Year
  • MLTX N/A
  • OFIX $5.51
  • P/E Ratio
  • MLTX N/A
  • OFIX N/A
  • Revenue Growth
  • MLTX N/A
  • OFIX 4.84
  • 52 Week Low
  • MLTX $5.95
  • OFIX $10.24
  • 52 Week High
  • MLTX $62.75
  • OFIX $20.73
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 23.29
  • OFIX 45.58
  • Support Level
  • MLTX $6.56
  • OFIX $14.10
  • Resistance Level
  • MLTX $7.48
  • OFIX $14.88
  • Average True Range (ATR)
  • MLTX 2.22
  • OFIX 0.48
  • MACD
  • MLTX -4.37
  • OFIX -0.12
  • Stochastic Oscillator
  • MLTX 6.07
  • OFIX 7.10

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

Share on Social Networks: